ATE525366T1 - Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten - Google Patents

Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten

Info

Publication number
ATE525366T1
ATE525366T1 AT03029917T AT03029917T ATE525366T1 AT E525366 T1 ATE525366 T1 AT E525366T1 AT 03029917 T AT03029917 T AT 03029917T AT 03029917 T AT03029917 T AT 03029917T AT E525366 T1 ATE525366 T1 AT E525366T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
preparations containing
containing same
benzoxazole derivatives
alkyl group
Prior art date
Application number
AT03029917T
Other languages
English (en)
Inventor
Yukiyoshi Yamazaki
Tsutomu Toma
Masahiro Nishikawa
Hidefumi Ozawa
Ayumu Okuda
Kazutoyo Abe
Soichi Oda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE525366T1 publication Critical patent/ATE525366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03029917T 2002-12-27 2003-12-29 Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten ATE525366T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/329,547 US6653334B1 (en) 2002-12-27 2002-12-27 Benzoxazole compound and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
ATE525366T1 true ATE525366T1 (de) 2011-10-15

Family

ID=29584242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03029917T ATE525366T1 (de) 2002-12-27 2003-12-29 Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten

Country Status (4)

Country Link
US (1) US6653334B1 (de)
EP (1) EP1433786B1 (de)
JP (1) JP4488732B2 (de)
AT (1) ATE525366T1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653334B1 (en) * 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
DE602004025569D1 (de) * 2003-06-18 2010-04-01 Tranzyme Pharma Inc Makrozyklische motilin rezeptorantagonisten
DE602004030344D1 (de) * 2003-07-31 2011-01-13 Tranzyme Pharma Inc Räumlich definierte makrocyclische verbindungen, die sich für die entdeckung von arzneimittel eignen
HRP20110009T1 (hr) * 2003-09-03 2011-03-31 Kowa Co. Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
GB0401334D0 (en) * 2004-01-21 2004-02-25 Novartis Ag Organic compounds
AP2007003980A0 (en) * 2004-11-23 2007-06-30 Pfizer Prod Inc Dibenzylamine compounds and derivatives
PL371841A1 (pl) * 2004-12-20 2006-06-26 ADAMED Sp.z o.o. Nowe związki pochodne kwasu 3-fenylopropionowego
US7301033B2 (en) * 2005-01-27 2007-11-27 Kowa Co., Ltd. PPAR-activating compound
WO2006082495A1 (en) * 2005-02-02 2006-08-10 Ranbaxy Laboratories Limited Peroxisome proliferator activated receptor modulators
EP1852426B1 (de) 2005-02-23 2013-11-13 Kowa Company, Ltd. Verfahren zur herstellung einer optisch aktiven ppar-aktivierenden verbindung und zwischenprodukt davon
JP4926955B2 (ja) * 2005-05-31 2012-05-09 興和株式会社 光学活性ｐｐａｒ活性化化合物及びその製造中間体の製造法
NZ566876A (en) 2005-09-29 2010-05-28 Sanofi Aventis Derivatives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
US7919506B2 (en) * 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) * 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
JP5243696B2 (ja) * 2006-03-17 2013-07-24 田辺三菱製薬株式会社 ベンゼン誘導体
US8088733B2 (en) * 2006-07-06 2012-01-03 Tranzyme Pharma Inc. Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK695A3 (en) 1992-07-03 1995-07-11 Smithkline Beecham Plc Heterocyclic compounds method of their production and using
WO1996004261A1 (en) 1994-07-29 1996-02-15 Smithkline Beecham Plc Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
GB9600464D0 (en) 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
AU1856997A (en) 1996-02-02 1997-08-22 Merck & Co., Inc. Method for raising hdl cholesterol levels
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
NZ515087A (en) * 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
HRP20010795A2 (en) * 1999-04-28 2003-02-28 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
WO2002046176A1 (en) * 2000-12-05 2002-06-13 Nippon Chemiphar Co., Ltd. Ppar (peroxisome proliferator activated receptor) activators
DE60216094T2 (de) * 2001-06-07 2007-06-06 Eli Lilly And Co., Indianapolis Modulatoren der peroxisom-proliferator-aktivierten rezeptoren (ppar)
JP4383177B2 (ja) * 2002-03-01 2009-12-16 スミスクライン ビーチャム コーポレーション ｈＰＰＡＲ活性化剤
US6653334B1 (en) * 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
EP1433786B1 (de) 2011-09-21
US6653334B1 (en) 2003-11-25
EP1433786A1 (de) 2004-06-30
JP2004210776A (ja) 2004-07-29
JP4488732B2 (ja) 2010-06-23

Similar Documents

Publication Publication Date Title
AU692090B2 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
AR044036A1 (es) Compuestos de pirazolopirimidinas y pirazolopiridinas como ligandos de receptor cannabinoide, composiciones farmaceuticas y usos de los mismos
DE60026318D1 (de) Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten
DE60315615D1 (de) Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
EA200401613A1 (ru) Лекарственное средство для лечения рака
BRPI0213243B8 (pt) composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
DE60329513D1 (de) Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff
EP1775289A4 (de) Neue imidazolidinderivate
SE0201937D0 (sv) Therapeutic agents
DK1043310T3 (da) Biphenylamidinderivater
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
ATE337318T1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
ATE482933T1 (de) Sulfopyrrolderivate
NO20042010L (no) 4-imidazolin-2-on forbindelser
DE60205338D1 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
ATE399755T1 (de) Aminoalkoholderivate, pharmazeutische zusammensetzungen, die diese enthalten, und verwendung davon
DE69919575D1 (de) Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69828087D1 (de) Aminderivate
ATE327238T1 (de) Pkb-3564-substanz mit die gefässneubildung hemmender wirkung
ATE420855T1 (de) 2-substituierte vitamin-d-derivate
TH51478A (th) อนุพันธ์เบนโซพิแรนที่ถูกแทนที่สำหรับรักษาการอักเสบ
TH52372A (th) สารประกอบและสารผสมสำหรับต้านพิคอร์นาไวรัส การใช้สารเหล่านี้ในทางเภสัชกรรม และวัสดุสำหรับการสังเคราะห์สารเหล่านี้

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties